Retinal Adaptation to Changing Glycemic Levels in a Rat Model of Type 2 Diabetes

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Johnson, Leif E ^a   Larsen, Michael ^a,b   Perez, Maria Thereza ^a,c  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; INSULIN GLARGINE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DEATH; CELL STRUCTURE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HISTOPATHOLOGY; HYPERGLYCEMIA; IMMUNOCYTOCHEMISTRY; MALE; MUELLER CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHOTORECEPTOR; PROTEIN EXPRESSION; RAT; RETINAL ADAPTATION; SENSORY SYSTEM ELECTROPHYSIOLOGY; TREATMENT OUTCOME; UPREGULATION; VISUAL ADAPTATION;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; ELECTRORETINOGRAPHY; MALE; RATS; RETINA;

EID: 84873622366     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055456     Document Type: Article

References (65)

1. Fletcher EL, Phipps JA, Ward MM, Puthussery T, Wilkinson-Berka JL, (2007) Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. Curr Pharm Des 13: 2699-2712.
2. Antonetti DA, Klein R, Gardner TW, (2012) Diabetic retinopathy. N Engl J Med 366: 1227-1239.
3. Kizawa J, Machida S, Kobayashi T, Gotoh Y, Kurosaka D, (2006) Changes of oscillatory potentials and photopic negative response in patients with early diabetic retinopathy. Jpn J Ophthalmol 50: 367-373.
4. Ola MS, Berkich DA, Xu Y, King MT, Gardner TW, et al. (2006) Analysis of glucose metabolism in diabetic rat retinas. Am J Physiol Endocrinol Metab 290: E1057-1067.
5. Puchowicz MA, Xu K, Magness D, Miller C, Lust WD, et al. (2004) Comparison of glucose influx and blood flow in retina and brain of diabetic rats. J Cereb Blood Flow Metab 24: 449-457.
6. Holfort SK, Jackson GR, Larsen M, (2010) Dark adaptation during transient hyperglycemia in type 2 diabetes. Exp Eye Res 91: 710-714.
7. Kurtenbach A, Mayser HM, Jägle H, Fritsche A, Zrenner E, (2006) Hyperoxia, hyperglycemia, and photoreceptor sensitivity in normal and diabetic subjects. Vis Neurosci 23: 651-661.
8. Holfort SK, Nørgaard K, Jackson GR, Hommel E, Madsbad S, et al. (2011) Retinal function in relation to improved glycaemic control in type 1 diabetes. Diabetologia 54: 1853-1861.
9. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
10. Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, et al. (1996) Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 13: 18-19.
11. Paulsen SJ, Vrang N, Larsen LK, Larsen PJ, Jelsing J, (2010) Stereological assessment of pancreatic beta-cell mass development in male Zucker Diabetic Fatty (ZDF) rats: correlation with pancreatic beta-cell function. J Anat 217: 624-630.
12. Amouzadeh HR, Sangiah S, (1990) Effects of streptozotocin-induced diabetes on xylazine-ketamine anesthesia. Vet Hum Toxicol 32: 19-22.
13. Wunderlich KA, Leveillard T, Penkowa M, Zrenner E, Perez MT, (2010) Altered expression of metallothionein-I and-II and their receptor megalin in inherited photoreceptor degeneration. Invest Ophthalmol Vis Sci 51: 4809-2480.
14. Sandberg MA, Lee H, Matthews GP, Gaudio AR, (1991) Relationship of oscillatory potential amplitude to A-wave slope over a range of flash luminances in normal subjects. Invest Ophthalmol Vis Sci 32: 1508-1516.
15. Reiter CE, Sandirasegarane L, Wolpert EB, Klinger M, Simpson IA, et al. (2003) Characterization of insulin signaling in rat retina in vivo and ex vivo. Am J Physiol Endocrinol Metab 285: E763-74.
16. Gjötterberg M. The electroretinogram in diabetic retinopathy, (1974) A clinical study and a critical survey. Acta Ophthalmol (Copenh) 52: 521-533.
17. Jenkins TC, Cartwright JP, (1990) The electroretinogram in minimal diabetic retinopathy. Br J Ophthalmol 74: 681-684.
18. Chung NH, Kim SH, Kwak MS, (1993) The electroretinogram sensitivity in patients with diabetes. Korean J Ophthalmol 7: 43-47.
19. Papakostopoulos D, Hart JC, Corrall RJ, Harney B, (1996) The scotopic electroretinogram to blue flashes and pattern reversal visual evoked potentials in insulin dependent diabetes. Int J Psychophysiol 21: 33-43.
20. Tyrberg M, Lindblad U, Melander A, Lövestam-Adrian M, Ponjavic V, et al. (2011) Electrophysiological studies in newly onset type 2 diabetes without visible vascular retinopathy. Doc Ophthalmol 123: 193-198.
21. Holfort SK, Klemp K, Kofoed PK, Sander B, Larsen M, (2010) Scotopic electrophysiology of the retina during transient hyperglycemia in type 2 diabetes. Invest Ophthalmol Vis Sci 51: 2790-2794.
22. Parmer R, Sheikh KH, Dawson WW, Toskes PP, (1982) A parallel change of taurine and the ERG in the developing rat retina. Comp Biochem Physiol C 72: 109-111.
23. Hancock HA, Kraft TW, (2004) Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci 45: 1002-1008.
24. Kohzaki K, Vingrys AJ, Bui BV, (2008) Early inner retinal dysfunction in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 49: 3595-3604.
25. Jamison JA, Bush RA, Lei B, Sieving PA, (2001) Characterization of the rod photoresponse isolated from the dark-adapted primate ERG. Vis Neurosci 18: 445-455.
26. Dang TM, Tsai TI, Vingrys AJ, Bui BV, (2011) Post-receptoral contributions to the rat scotopic electroretinogram a-wave. Doc Ophthalmol 122: 149-156.
27. Sakai H, Tani Y, Shirasawa E, Shirao Y, Kawasaki K, (1995) Development of electroretinographic alterations in streptozotocin-induced diabetes in rats. Ophthalmic Res 27: 57-63.
28. Bui BV, Armitage JA, Tolcos M, Cooper ME, Vingrys AJ, (2003) ACE inhibition salvages the visual loss caused by diabetes. Diabetologia 46: 401-408.
29. Matsubara H, Kuze M, Sasoh M, Ma N, Furuta M, et al. (2006) Time-dependent course of electroretinograms in the spontaneous diabetic Goto-Kakizaki rat. Jpn J Ophthalmol 50: 211-216.
30. Yoshida Y, Yamagishi S, Matsui T, Jinnouchi Y, Fukami K, et al. (2009) Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy. Diabetes Metab Res Rev 25: 678-686.
31. Huber M, Heiduschka P, Ziemssen F, Bolbrinker J, Kreutz R, (2011) Microangiopathy and visual deficits characterize the retinopathy of a spontaneously hypertensive rat model with type 2 diabetes and metabolic syndrome. Hypertens Res 34: 103-112.
32. Zhang SX, Ma JX, Sima J, Chen Y, Hu MS, et al. (2005) Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy. Am J Pathol 166: 313-321.
33. Kern TS, Miller CM, Tang J, Du Y, Ball SL, et al. (2010) Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop. Mol Vis 16: 1629-1639.
34. Charng J, Nguyen CT, Bui BV, Vingrys AJ, (2011) Age-related retinal function changes in albino and pigmented rats. Invest Ophthalmol Vis Sci 52: 8891-8899.
35. LaVail MM, Battelle BA, (1975) Influence of eye pigmentation and light deprivation on inherited retinal dystrophy in the rat. Exp Eye Res 21: 167-192.
36. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, et al. (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102: 783-791.
37. Zeng XX, Ng YK, Ling EA, (2000) Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci 17: 463-471.
38. Gonçalves A, Leal E, Paiva A, Teixeira Lemos E, Teixeira F, et al. (2012) Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model. Diabetes Obes Metab 14: 454-463.
39. Fox DA, Hamilton WR, Johnson JE, Xiao W, Chaney S, et al. (2011) Gestational lead exposure selectively decreases retinal dopamine amacrine cells and dopamine content in adult mice. Toxicol Appl Pharmacol 256: 258-267.
40. Rothenberg SJ, Schnaas L, Salgado-Valladares M, Casanueva E, Geller AM, et al. (2002) Increased ERG a- and b-wave amplitudes in 7- to 10-year-old children resulting from prenatal lead exposure. Invest Ophthalmol Vis Sci 43: 2036-2044.
41. Horsburgh GM, Sefton AJ, (1987) Cellular degeneration and synaptogenesis in the developing retina of the rat. J Comp Neurol 263: 553-566.
42. Hussain AA, Willmott NJ, Voaden MJ, (1992) Cyclic GMP, calcium and photoreceptor sensitivity in mice heterozygous for the rod dysplasia gene designated "rd". Vision Res 32: 29-36.
43. Schneider T, Zrenner E, (1986) The influence of phosphodiesterase inhibitors on ERG and optic nerve response of the cat. Invest Ophthalmol Vis Sci 27: 1395-1403.
44. Gosbell A, Favilla I, Jablonski P, (1996) The effects of insulin on the electroretinogram of bovine retina in vitro. Curr Eye Res 15: 1132-1137.
45. Lansel N, Niemeyer G, (1997) Effects of insulin under normal and low glucose on retinal electrophysiology in the perfused cat eye. Invest Ophthalmol Vis Sci 38: 792-799.
46. Misra GP, Singh RS, Aleman TS, Jacobson SG, Gardner TW, (2009) Subconjunctivally implantable hydrogels with degradable and thermoresponsive properties for sustained release of insulin to the retina. Biomaterials 30: 6541-6547.
47. Klemp K, Sander B, Brockhoff PB, Vaag A, Lund-Andersen H, et al. (2005) The multifocal ERG in diabetic patients without retinopathy during euglycemic clamping. Invest Ophthalmol Vis Sci 46: 2620-2626.
48. Khan MI, Barlow RB, Weinstock RS, (2011) Acute hypoglycemia decreases central retinal function in the human eye. Vision Res 51: 1623-1626.
49. Winkler BS, (1981) Glycolytic and oxidative metabolism in relation to retinal function. J Gen Physiol 77: 667-692.
50. Kang Derwent JJ, Linsenmeier RA, (2001) Hypoglycemia increases the sensitivity of the cat electroretinogram to hypoxemia. Vis Neurosci 18: 983-993.
51. Rimmer T, Linsenmeier RA, (1993) Resistance of diabetic rat electroretinogram to hypoxemia. Invest Ophthalmol Vis Sci 34: 3246-3252.
52. Wright WS, McElhatten RM, Messina JE, Harris NR, (2010) Hypoxia and the expression of HIF-1alpha and HIF-2alpha in the retina of streptozotocin-injected mice and rats. Exp Eye Res 90: 405-412.
53. Santos JM, Tewari S, Goldberg AF, Kowluru RA, (2011) Mitochondrial biogenesis and the development of diabetic retinopathy. Free Radic Biol Med 51: 1849-1860.
54. Dawson WW, Hazariwala K, Karges S, (2000) Human photopic response to circulating glucose. Doc Ophthalmol 101: 155-163.
55. Kappelgaard P, Hansen KB, Vilsbøll T, Knop FK, Larsen M, (2012) Electroretinography in healthy subjects in relation to systemic glucocorticoid intake. Doc Ophthalmol 124: 49-57.
56. Hirsch-Hoffmann C, Niemeyer G, (1993) Changes in plasma glucose level affect rod-, but not cone-ERG in the anesthetized cat. Clin. Vision Sci 8: 489-501.
57. Hahn I, Wachtmeister L, (1989) Spatial summation and visual adaptation in the inner part of the frog retina. Acta Ophthalmol (Copenh) 67: 131-136.
58. Hardy KJ, Fisher C, Heath P, Foster DH, Scarpello JH, (1995) Comparison of colour discrimination and electroretinography in evaluation of visual pathway dysfunction in aretinopathic IDDM patients. Br J Ophthalmol 79: 35-37.
59. Danis RP, Yang Y, (1993) Microvascular retinopathy in the Zucker diabetic fatty rat. Invest Ophthalmol Vis Sci 34: 2367-2371.
60. Behl Y, Krothapalli P, Desta T, DiPiazza A, Roy S, et al. (2008) Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am J Pathol 172: 1411-1418.
61. Abiko T, Abiko A, Clermont AC, Shoelson B, Horio N, et al. (2003) Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation. Diabetes 52: 829-837.
62. Mizutani M, Gerhardinger C, Lorenzi M, (1998) Müller cell changes in human diabetic retinopathy. Diabetes 47: 445-449.
63. Barber AJ, Antonetti DA, Gardner TW, (2000) Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Invest Ophthalmol Vis Sci 41: 3561-3568.
64. Iandiev I, Pannicke T, Reichenbach A, Wiedemann P, Bringmann A, (2007) Diabetes alters the localization of glial aquaporins in rat retina. Neurosci Lett 421: 132-136.
65. Kowluru RA, (2003) Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 52: 818-823.